21696296

Source:http://linkedlifedata.com/resource/pubmed/id/21696296

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:21696296	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:21696296	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:21696296	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:21696296	lifeskim:mentions	umls-concept:C0278678	lld:lifeskim
pubmed-article:21696296	lifeskim:mentions	umls-concept:C1512474	lld:lifeskim
pubmed-article:21696296	lifeskim:mentions	umls-concept:C1998098	lld:lifeskim
pubmed-article:21696296	lifeskim:mentions	umls-concept:C0282460	lld:lifeskim
pubmed-article:21696296	lifeskim:mentions	umls-concept:C0205269	lld:lifeskim
pubmed-article:21696296	pubmed:issue	7	lld:pubmed
pubmed-article:21696296	pubmed:dateCreated	2011-7-11	lld:pubmed
pubmed-article:21696296	pubmed:abstractText	To evaluate the activity of panobinostat in refractory renal carcinoma.	lld:pubmed
pubmed-article:21696296	pubmed:language	eng	lld:pubmed
pubmed-article:21696296	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21696296	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:21696296	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21696296	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21696296	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21696296	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:21696296	pubmed:month	Aug	lld:pubmed
pubmed-article:21696296	pubmed:issn	1532-4192	lld:pubmed
pubmed-article:21696296	pubmed:author	pubmed-author:HainsworthJoh...	lld:pubmed
pubmed-article:21696296	pubmed:author	pubmed-author:SpigelDavid...	lld:pubmed
pubmed-article:21696296	pubmed:author	pubmed-author:ArrowsmithEdw...	lld:pubmed
pubmed-article:21696296	pubmed:author	pubmed-author:BocciaRalph...	lld:pubmed
pubmed-article:21696296	pubmed:author	pubmed-author:BurrisHoward...	lld:pubmed
pubmed-article:21696296	pubmed:author	pubmed-author:InfanteJeffre...	lld:pubmed
pubmed-article:21696296	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:21696296	pubmed:volume	29	lld:pubmed
pubmed-article:21696296	pubmed:owner	NLM	lld:pubmed
pubmed-article:21696296	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:21696296	pubmed:pagination	451-5	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:meshHeading	pubmed-meshheading:21696296...	lld:pubmed
pubmed-article:21696296	pubmed:year	2011	lld:pubmed
pubmed-article:21696296	pubmed:articleTitle	A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma.	lld:pubmed
pubmed-article:21696296	pubmed:affiliation	Sarah Cannon Research Institute, Nashville, TN 37203, USA. jhainsworth@tnonc.com	lld:pubmed
pubmed-article:21696296	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:21696296	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:21696296	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed